Embecta Corp.

NasdaqGS:EMBC Stock Report

Market Cap: US$516.4m

Embecta Future Growth

Future criteria checks 1/6

Embecta is forecast to grow earnings and revenue by 5.7% and 0.1% per annum respectively while EPS is expected to grow by 3.7% per annum.

Key information

5.7%

Earnings growth rate

3.73%

EPS growth rate

Medical Equipment earnings growth15.9%
Revenue growth rate0.1%
Future return on equityn/a
Analyst coverage

Low

Last updated13 Apr 2026

Recent future growth updates

Earnings Beat: Embecta Corp. Just Beat Analyst Forecasts, And Analysts Have Been Updating Their Models

Feb 09
Earnings Beat: Embecta Corp. Just Beat Analyst Forecasts, And Analysts Have Been Updating Their Models

US$16.67: That's What Analysts Think Embecta Corp. (NASDAQ:EMBC) Is Worth After Its Latest Results

Nov 28
US$16.67: That's What Analysts Think Embecta Corp. (NASDAQ:EMBC) Is Worth After Its Latest Results

Recent updates

EMBC: Higher Discount Rate And Wound Care Expansion Will Support Future Upside

Analysts have adjusted Embecta's implied fair value price target from $16.67 to $15.00, reflecting updated views on discount rates, revenue trends, profit margins and future P/E assumptions following recent research, including price target cuts from both Mizuho and BTIG. Analyst Commentary Recent research updates point to a more cautious stance on Embecta, with the lower implied fair value aligning with trimmed price targets and more conservative assumptions around growth, profitability and P/E levels.

Embecta: An Interesting Deal At An Interesting Time

Mar 19

EMBC: Future M&A And Margin Pressures Will Shape Balanced Outlook

Analysts have maintained Embecta's price target at $11.00, citing updated assumptions that include a slightly lower discount rate, softer revenue growth expectations, a reduced profit margin outlook, and a higher future P/E multiple. What's in the News Embecta is actively exploring mergers and acquisitions, with leadership emphasizing a focus on chronic care drug delivery where the company can use its manufacturing strengths and growing B2B channel (Key Developments).

Embecta's (NASDAQ:EMBC) Solid Earnings Have Been Accounted For Conservatively

Feb 12
Embecta's (NASDAQ:EMBC) Solid Earnings Have Been Accounted For Conservatively

Earnings Beat: Embecta Corp. Just Beat Analyst Forecasts, And Analysts Have Been Updating Their Models

Feb 09
Earnings Beat: Embecta Corp. Just Beat Analyst Forecasts, And Analysts Have Been Updating Their Models

Embecta (NASDAQ:EMBC) Will Pay A Dividend Of $0.15

Feb 08
Embecta (NASDAQ:EMBC) Will Pay A Dividend Of $0.15

EMBC: Future M&A Plans Will Test Balance Sheet And Earnings Multiple

Analysts now hold their fair value estimate for Embecta at US$11.00. The unchanged target reflects modest tweaks to assumptions around revenue growth, profit margin and future P/E that offset the slightly higher discount rate.

EMBC: Future M&A Ambitions Will Heighten Risk Against Weak Earnings Multiple

Analysts have kept their fair value estimate for Embecta steady at US$11.00 while slightly adjusting underlying assumptions around discount rate, revenue growth, profit margins, and forward P/E. This reflects updated views on the company’s risk profile and earnings power without a change to the headline target.

Market Cool On Embecta Corp.'s (NASDAQ:EMBC) Earnings

Jan 09
Market Cool On Embecta Corp.'s (NASDAQ:EMBC) Earnings

EMBC: Medium Term Guidance Will Balance Revenue Outlook With Margin Pressures

Analysts have modestly trimmed their price target on Embecta to 11.00 dollars, reflecting slightly higher discount rate assumptions and a marginally lower anticipated future P or E multiple, partially offset by incrementally stronger expectations for revenue growth and profit margins. What's in the News Embecta issued new fiscal 2026 guidance, projecting reported revenues between 1,071 million and 1,093 million dollars, signaling confidence in its medium term growth trajectory (Key Developments).

EMBC: Outlook Will Balance Stabilizing Revenues With Pressured Profit Margins Through 2026

Analysts have modestly raised their price target on Embecta to 11.00 dollars from 11.00 dollars. This reflects improved expectations for a return to positive revenue growth and a higher future earnings multiple, partially offset by a higher discount rate and slightly lower projected profit margins.

US$16.67: That's What Analysts Think Embecta Corp. (NASDAQ:EMBC) Is Worth After Its Latest Results

Nov 28
US$16.67: That's What Analysts Think Embecta Corp. (NASDAQ:EMBC) Is Worth After Its Latest Results

Is Now The Time To Look At Buying Embecta Corp. (NASDAQ:EMBC)?

Nov 01
Is Now The Time To Look At Buying Embecta Corp. (NASDAQ:EMBC)?

Embecta Corp.'s (NASDAQ:EMBC) Intrinsic Value Is Potentially 99% Above Its Share Price

Sep 26
Embecta Corp.'s (NASDAQ:EMBC) Intrinsic Value Is Potentially 99% Above Its Share Price

Even With A 29% Surge, Cautious Investors Are Not Rewarding Embecta Corp.'s (NASDAQ:EMBC) Performance Completely

Aug 28
Even With A 29% Surge, Cautious Investors Are Not Rewarding Embecta Corp.'s (NASDAQ:EMBC) Performance Completely

GLP-1 Partnerships Will Expand Global Healthcare Reach

The consensus price target for Embecta has been cut from $18.33 to $16.00, primarily reflecting lowered revenue growth forecasts and a declining future P/E multiple. What's in the News Embecta Corp.

Sentiment Still Eluding Embecta Corp. (NASDAQ:EMBC)

Jul 04
Sentiment Still Eluding Embecta Corp. (NASDAQ:EMBC)

Embecta (NASDAQ:EMBC) Has Announced A Dividend Of $0.15

May 22
Embecta (NASDAQ:EMBC) Has Announced A Dividend Of $0.15

What Is Embecta Corp.'s (NASDAQ:EMBC) Share Price Doing?

May 09
What Is Embecta Corp.'s (NASDAQ:EMBC) Share Price Doing?

Embecta Corp.'s (NASDAQ:EMBC) Intrinsic Value Is Potentially 87% Above Its Share Price

Mar 06
Embecta Corp.'s (NASDAQ:EMBC) Intrinsic Value Is Potentially 87% Above Its Share Price

Embecta: Weak Outlook But Mouth-Watering Valuation Skew Risk-Reward In Favour

Feb 28

New Initiatives Expected To Make Embecta More Profitable

Dec 04

Embecta (NASDAQ:EMBC) Is Due To Pay A Dividend Of $0.15

Nov 29
Embecta (NASDAQ:EMBC) Is Due To Pay A Dividend Of $0.15

At US$16.33, Is It Time To Put Embecta Corp. (NASDAQ:EMBC) On Your Watch List?

Nov 07
At US$16.33, Is It Time To Put Embecta Corp. (NASDAQ:EMBC) On Your Watch List?

It's A Story Of Risk Vs Reward With Embecta Corp. (NASDAQ:EMBC)

Sep 24
It's A Story Of Risk Vs Reward With Embecta Corp. (NASDAQ:EMBC)
User avatar

Expanding Global Leadership In Insulin Devices Fuels Revenue Growth And Operational Efficiencies

Strengthening the base business in insulin injection devices suggests potential for stable, growing revenues as the global demographic needing these devices increases.

Embecta (NASDAQ:EMBC) Will Pay A Dividend Of $0.15

Aug 16
Embecta (NASDAQ:EMBC) Will Pay A Dividend Of $0.15

Embecta Corp. Just Beat EPS By 79%: Here's What Analysts Think Will Happen Next

Aug 14
Embecta Corp. Just Beat EPS By 79%: Here's What Analysts Think Will Happen Next

When Should You Buy Embecta Corp. (NASDAQ:EMBC)?

Jul 13
When Should You Buy Embecta Corp. (NASDAQ:EMBC)?

Earnings Beat: Embecta Corp. Just Beat Analyst Forecasts, And Analysts Have Been Updating Their Models

May 12
Earnings Beat: Embecta Corp. Just Beat Analyst Forecasts, And Analysts Have Been Updating Their Models

Embecta's (NASDAQ:EMBC) Dividend Will Be $0.15

Feb 21
Embecta's (NASDAQ:EMBC) Dividend Will Be $0.15

Earnings and Revenue Growth Forecasts

NasdaqGS:EMBC - Analysts future estimates and past financials data (USD Millions)
DateRevenueEarningsFree Cash FlowCash from OpAvg. No. Analysts
9/30/20281,078165152N/A3
9/30/20271,071152154N/A4
9/30/20261,071149140N/A4
12/31/20251,080140206214N/A
9/30/20251,08095182192N/A
6/30/20251,10384132134N/A
3/31/20251,080534051N/A
12/31/20241,108582944N/A
9/30/20241,123782036N/A
6/30/20241,119701439N/A
3/31/20241,13370932N/A
12/31/20231,12255-30-6N/A
9/30/20231,121704168N/A
6/30/20231,114477096N/A
3/31/20231,11994114138N/A
12/31/20221,116160309334N/A
9/30/20221,130224388412N/A
6/30/20221,156338411440N/A
3/31/20221,160380506537N/A
12/31/20211,169408442474N/A
9/30/20211,165415417456N/A
9/30/20201,086428457499N/A
9/30/20191,109432N/A505N/A

Analyst Future Growth Forecasts

Earnings vs Savings Rate: EMBC's forecast earnings growth (5.7% per year) is above the savings rate (3.4%).

Earnings vs Market: EMBC's earnings (5.7% per year) are forecast to grow slower than the US market (16.1% per year).

High Growth Earnings: EMBC's earnings are forecast to grow, but not significantly.

Revenue vs Market: EMBC's revenue (0.1% per year) is forecast to grow slower than the US market (11% per year).

High Growth Revenue: EMBC's revenue (0.1% per year) is forecast to grow slower than 20% per year.

Earnings per Share Growth Forecasts

Future Return on Equity

Future ROE: Insufficient data to determine if EMBC's Return on Equity is forecast to be high in 3 years time

Discover growth companies

7D

1Y

7D

1Y

7D

1Y

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2026/04/30 16:41
End of Day Share Price 2026/04/29 00:00
Earnings2025/12/31
Annual Earnings2025/09/30

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* Example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.

Analyst Sources

Embecta Corp. is covered by 7 analysts. 4 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution
Travis SteedBofA Global Research
Travis SteedBofA Global Research
Michael GormanBTIG